A Phase 4, Randomised Vaccination Study in Healthy Adults to Investigate the Effects of Acellular Pertussis Vaccine on Colonisation With Bordetella Pertussis Using Controlled Human Infection
Clinical trial NCT06903221 · ACTIVE_NOT_RECRUITING
Trial details
- NCT number
- NCT06903221
- Sponsor
- Dimitri Diavatopoulos
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- Phase 4
- Study type
- INTERVENTIONAL
- Start date
- 2024-10-16
- Primary completion
- 2026-10-01
- Enrollment
- 99
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.